Your browser doesn't support javascript.
loading
: 20 | 50 | 100
1 - 16 de 16
2.
Ann Fr Anesth Reanim ; 20(2): 159-70, 2001 Feb.
Article Fr | MEDLINE | ID: mdl-11270237

In status epilepticus, the optimal efficacy of the antiepileptic drugs depends notably on effective, quickly reached and sufficiently lasting cerebral concentrations and the optimal tolerability notably on the lack of excessive storage in the brain and other tissues. So, the best efficacy-tolerability ratio of these drugs is largely determined by their pharmacokinetic properties. A linear kinetics, a not too short distribution half-life, a neither too brief nor too long elimination half-life, a fast and easy crossing of the blood-brain barrier and the lack of long-lasting accumulation in fat tissues are among the main ideal pharmacokinetic properties. Any of the antiepileptic drugs currently used in status epilepticus has all these properties together. An accurate knowledge of the pharmacokinetics is absolutely crucial to rationally decide the route of administration, the loading dose and the maintenance doses. However, pharmacokinetics must only complete, but cannot replace, the clinical experience and judgement, especially because some limitations: kinetic equations are mathematically exact but theoretical; individual kinetics in a given patient is exceptionally known in clinical practice; finally the pharmacokinetics may be significantly modified during a status epilepticus, especially of the generalized convulsive type, due to systemic consequences and complications of the seizures. In the emergency situation of status epilepticus, the correlation between the clinical efficacy and the so-called "therapeutic" plasma levels remains ill defined. The reported values are often very high and their range appears very large. Nevertheless plasma levels are useful, especially for the monitoring of the evolution; they are mandatory for nonlinear-kinetics drugs.


Anticonvulsants/pharmacokinetics , Anticonvulsants/therapeutic use , Status Epilepticus/drug therapy , Adult , Humans , Status Epilepticus/metabolism
3.
Arch Neurol ; 56(8): 927-32, 1999 Aug.
Article En | MEDLINE | ID: mdl-10448797

BACKGROUND: Clinical features that may help to differentiate medial temporal lobe epilepsy (MTLE) from neocortical temporal lobe epilepsy (NTLE) are lacking. OBJECTIVE: To investigate the localizing and lateralizing value of the association of ipsilateral motor automatisms and contralateral dystonic posturing in patients with medically refractory temporal lobe epilepsy. PATIENTS AND METHODS: Videotapes of 60 patients with well-defined MTLE, NTLE, or both were reviewed to assess the presence and the localizing value of unilateral dystonic posturing associated with motor automatisms. RESULTS: Twenty-eight of the 60 patients exhibited unilateral dystonic posturing. This sign was observed in patients with MTLE and NTLE. It was mostly contralateral to the seizure focus in patients with MTLE and exclusively ipsilateral in patients with NTLE. Unilateral motor automatisms occurred in 26 of the 60 patients with MTLE or NTLE. It was predominantly ipsilateral to the seizure focus in patients with MTLE and exclusively contralateral in patients with NTLE. The association of ipsilateral motor automatisms and contralateral dystonic posturing was found in 14 patients with MTLE but in none of the patients with NTLE. Two patients who had medial and neocortical seizure onset also exhibited this clinical feature. This association was not significantly correlated with the postoperative outcome in patients with MTLE. CONCLUSIONS: The association of ipsilateral motor automatisms and contralateral dystonic posturing may help to differentiate MTLE from NTLE with a reliable lateralizing value. This clinical association may reflect a specific pattern in the spread of the ictal discharge.


Automatism/complications , Dystonia/complications , Epilepsy, Temporal Lobe/complications , Functional Laterality/physiology , Posture , Psychomotor Performance/physiology , Adult , Atrophy/pathology , Atrophy/surgery , Automatism/diagnosis , Dystonia/diagnosis , Electroencephalography , Epilepsy, Temporal Lobe/metabolism , Epilepsy, Temporal Lobe/surgery , Female , Follow-Up Studies , Hippocampus/pathology , Hippocampus/surgery , Humans , Male , Middle Aged , Postoperative Care , Retrospective Studies , Severity of Illness Index , Temporal Lobe/metabolism , Video Recording
4.
Neurology ; 51(5): 1256-62, 1998 Nov.
Article En | MEDLINE | ID: mdl-9818842

BACKGROUND: We investigated the prognostic value of the type of epilepsies and epileptic syndromes for seizure recurrence. In patients with partial epilepsy, we focused on the prognostic value of any structural brain abnormality and of the location of the epileptogenic region. METHODS: A total of 2,200 adult outpatients were included in a hospital-based observational survey, with a follow-up of 1 to 7 years. Twenty-two percent of the patients exhibited generalized epilepsy, 62% partial epilepsy, and 16% undetermined epilepsy. RESULTS: Seizure control (>1 year without seizure) was achieved in 82% of patients who had idiopathic generalized epilepsy, 35% of those with symptomatic partial epilepsy, 45% of those with cryptogenic partial epilepsy, and 11% of those with partial epilepsy associated with hippocampal sclerosis (HS). Temporal lobe epilepsy (TLE) was the most refractory partial epilepsy, with only 20% of such patients remaining seizure free, compared with 36% of extra-TLE patients. In partial epilepsy, HS, cerebral dysgenesis, and dual pathology (HS and another lesion) were associated with a low rate of seizure-free patients (11%, 24%, and 3%, respectively). No significant difference in seizure control was found between patients with extra-TLE and those with TLE and no HS. CONCLUSIONS: In adults, partial epilepsy is more difficult to treat than idiopathic generalized epilepsy. In patients who have partial epilepsy, the location of the epileptogenic zone does not seem to be a determining factor. Brain abnormalities--especially HS, either alone or associated with another lesion--are a major prognostic factor.


Epilepsy/etiology , Epilepsy/physiopathology , Adolescent , Adult , Brain/pathology , Databases as Topic , Epilepsies, Partial/classification , Epilepsies, Partial/etiology , Epilepsies, Partial/physiopathology , Epilepsy/classification , Female , Follow-Up Studies , Humans , Magnetic Resonance Imaging , Male , Multivariate Analysis , Prognosis , Recurrence
7.
Article En | MEDLINE | ID: mdl-2505493

The aim of a Stereo-EEG investigation is to verify and prove that the hypothesis, done on the basis of the preliminary investigations (clinical, EEG, neuroradiological), are correct. This task is particularly hard in frontal lobe epilepsies, because of anatomical and physiopathological reasons. Among 277 consecutive patients, 86 were explored for a probable frontal epilepsy. The stereotactically introduced electrodes. 1) simultaneously record the electrical activity on both, mesial and lateral cortical areas, and, 2) in 3/4 of cases also investigate extra-frontal, mainly temporal, areas. Two small, non-surgical haematomas were provoked in one patient. The spatial trajectory of the discharges, evaluated with this methodology, permits of limiting the surgical removal in many cases.


Electroencephalography , Epilepsies, Partial/physiopathology , Frontal Lobe/physiopathology , Stereotaxic Techniques , Adolescent , Adult , Brain Mapping/instrumentation , Child , Child, Preschool , Dominance, Cerebral/physiology , Electrodes, Implanted , Electroencephalography/instrumentation , Epilepsies, Partial/surgery , Evoked Potentials , Frontal Lobe/surgery , Humans , Middle Aged , Stereotaxic Techniques/instrumentation
8.
Article Fr | MEDLINE | ID: mdl-3296040

The neuroradiological stereotactic examinations provide indispensable information to localize many intracranial lesions: the data obtained by the CT-Scan are complementary of the stereotactic ones. The transfer of the routine CT-Scan transverse axial slices into the Talairach stereotactic system needs a precise definition of the inclination of the plan of the slices and a correct evaluation of the mean magnification factor. The inclination of the slices is appreciated using the bony, vascular and ventricular landmarks clearly identified on the CT-Scan and stereoscopic stereotactic images. We compared the spatial "reconstructed" CT-Scan data with the histopathological findings obtained by serial stereotactic biopsies in 48 tumor patients. The error varied from 1.5 to 4.6% (m: 2.7 +/- 1.2) on the sagittal plane; from 1.3 to 10% (m: 5.8 +/- 3.4) on the transversal plane; from 2.5 to 4.3% (m: 3.5 +/- 0.7) on the axial plane. The mean global error was 3.7% +/- 2.3. The CT-Scan directly performed under stereotactic conditions (acrylic frame) seems to be the more useful procedure. Nevertheless considering the good precision obtained with our methodology applied to the Talairach's system, we consider it suitable when: a) the gantry of the CT-Scan apparatus is too narrow for the acrylic frame; b) the exploitation of previous CT-Scan examinations is necessary; c) patient refuses the discomfort of the acrylic frame.


Brain Diseases/diagnostic imaging , Stereotaxic Techniques , Tomography, X-Ray Computed , Brain Diseases/pathology , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Humans
9.
Article Fr | MEDLINE | ID: mdl-3296042

This study concerns 180 patients (132 M; 48 F) (age: 2 to 69 years; m: 33 years) who underwent stereotactic procedures according to the methodology of Talairach and Szikla. Such procedures (stereotactic and stereoscopic angiography in all cases, and ventriculography in 81%) should permit a correct spatial definition of intracranial lesions. The informations provided by the angiography (normal in 7%) and by the ventriculography (normal in 11%) are complementary to those yielded by the TDM and permit an easier and safe stereotactic approach to the lesions. In 43% of patients the lesions were deep-seated (basal ganglia: 24; sellar region: 19; thalamo-peduncular: 13; brain stem: 6, etc.). The histological examination showed: low-grade gliomas in 43%; glioblastomas in 21%; non tumoral lesions in 17%. A precise diagnosis couldn't be obtained in 3.8%. The data provided by the stereo-EEG (in 11 patients suffering also of severe drug-resistant partial epilepsy) did not permit, alone, an histological diagnosis, excepted when electrodes explored a solid tumor. Two patients had a neurological impairment, and two died (one for extracerebral reasons). The authors consider that the TDM data and the informations given by the stereotactic procedures are complementary for obtaining valuable informations on the spatial organization of intracranial lesions and choosing the best treatment.


Brain Diseases/diagnostic imaging , Stereotaxic Techniques , Tomography, X-Ray Computed , Adolescent , Adult , Aged , Biopsy/methods , Brain Diseases/pathology , Brain Neoplasms/diagnostic imaging , Brain Neoplasms/pathology , Cerebral Angiography , Cerebral Ventriculography , Child , Child, Preschool , Electroencephalography/methods , Female , Humans , Male , Middle Aged
10.
Eur Neurol ; 26(2): 113-9, 1987.
Article En | MEDLINE | ID: mdl-3830207

A long-term open multicenter trial was carried out in 15 European centers with therapy-resistant epileptics to evaluate the efficacy and safety of progabide, a new antiepileptic GABA receptor agonist; 187 patients, suffering from partial epilepsy (57%), primary generalized epilepsy (20%), secondary generalized epilepsy (21%), and unclassified generalized epilepsy (2%), participated in the study. All patients had a total seizure frequency higher than one per month in spite of standard antiepileptic medication; 46% had a mean partial seizure frequency from daily to weekly. Progabide was administered at a mean daily dose of 30.5 mg/kg/day as an add-on to the standard antiepileptic drugs up to one year in 115 patients; 37 patients (19.8%) dropped out because of reasons which were not drug-related (bad compliance, lost to follow-up); in 12 patients (6.5%) progabide was withdrawn for side effects and in 20 (10.7%) for lack of efficacy. 71.3% of patients treated for one year (62% considering the 'cumulative' number of patients) experienced more than a 50% reduction in seizure frequency. This reduction was equally present in patients with partial epilepsy (63.9%) and with generalized epilepsy (62.2% of patients with primary and 57.1% with secondary generalized epilepsy). No signs of tolerance phenomena to the antiepileptic effect of progabide were observed. No side effects were reported in 56.7% of the patients. Clinical side effects were mild and transient, leading to progabide discontinuation in 6.5% of the patients only; an increase in SGPT was observed in 5.7% of the patients, these increases were transient and without any clinical symptom.(ABSTRACT TRUNCATED AT 250 WORDS)


Anticonvulsants/therapeutic use , Epilepsy/drug therapy , gamma-Aminobutyric Acid/analogs & derivatives , Adolescent , Adult , Anticonvulsants/adverse effects , Anticonvulsants/blood , Child , Child, Preschool , Dose-Response Relationship, Drug , Epilepsy/blood , Female , Humans , Infant , Male , Middle Aged , gamma-Aminobutyric Acid/adverse effects , gamma-Aminobutyric Acid/blood , gamma-Aminobutyric Acid/therapeutic use
12.
Rev Neurol (Paris) ; 141(4): 315-7, 1985.
Article Fr | MEDLINE | ID: mdl-4012147

A 45-year-old male received split course multiple daily fractionated radiotherapy for an anaplastic left parieto-temporal astrocytoma. A total dose of 60 grays was delivered by 15 fractions of 2 grays given in 5 days and repeated after a rest period of 15 days. Forty grays were delivered to the whole brain and 20 grays to the tumor area. No surgery or radiosensitizer or chemotherapy were used at any time. The patient noted progressive loss of vision in both eyes and became blind 9 months after irradiation. Post-mortem study revealed 2 areas of radionecrosis in the chiasma and corpus callosum, corresponding to the dose of 57-60 grays. The necrotic area were at a distance of the tumor remnants. The high Daily Dose Multifractionation schedule may be responsible for the radionecrosis.


Astrocytoma/radiotherapy , Brain Neoplasms/radiotherapy , Optic Chiasm/radiation effects , Radiation Injuries/pathology , Humans , Male , Middle Aged , Necrosis , Optic Chiasm/pathology , Parietal Lobe , Radiotherapy Dosage , Temporal Lobe
13.
Ann Med Interne (Paris) ; 132(8): 563-7, 1981.
Article Fr | MEDLINE | ID: mdl-7337333

The authors report the case of a 71 year old woman affected by a solitary intracranial plasmacytoma. Computed tomography statement and monoclonal gammapathy found in the serum and in the cerebrospinal fluid permitted the diagnosis. Brain tumor and gammapathy improved after radiotherapy. A review of the 17 cases reported in the available literature showed some characteristics of these tumors : epidemiology, localization, evolution.


Brain Neoplasms/diagnosis , Plasmacytoma/diagnosis , Aged , Brain Neoplasms/complications , Female , Humans , Hypergammaglobulinemia/complications , Immunoglobulin G , Plasmacytoma/complications , Tomography, X-Ray Computed
15.
Rev Neurol (Paris) ; 135(11): 775-87, 1979.
Article Fr | MEDLINE | ID: mdl-555019

The authors report 5 cases of avoiding phenomenon of the hand from parietal lesions. Four of these patients were operated for intractable epilepsy, from a parietal cortectomy that implicated a certain amount of white matter. The avoiding phenomena observed are analyzed as elementary motor perturbations rather than a disturbance of motor comportment. The authors distinguish two types of avoiding phenomena: 1--Avoiding phenomenon of dystonic type occurs during any motor activity and persists during all its development. It is probably related to the removal of the cortex of the post-central gyrus and of the anterior part of the superior parietal lobule; 2--The initial avoiding phenomenon is brief and occurs only at the beginning of the movements which implicate solely the upper limb; it seems related to the removal of the internal part of the superior parietal lobule that corresponds approximately to areas 5 and 7 from Brodmann. Some hypotheses are discussed concerning the possible physio-pathological mechanisms of these disturbances.


Cerebral Decortication/adverse effects , Cerebral Infarction/complications , Movement Disorders/etiology , Parietal Lobe/surgery , Adolescent , Adult , Cerebral Infarction/pathology , Child , Dystonia/etiology , Dystonia/pathology , Epilepsy/surgery , Female , Humans , Male , Middle Aged , Movement Disorders/pathology , Parietal Lobe/blood supply , Parietal Lobe/pathology
...